Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Losartan potassium

Losartan potassium

pharmaceutical raw materials
Losartan potassium structure

Losartan potassium 

structure
  • CAS No:

    124750-99-8

  • Formula:

    C22H23ClN6O.K

  • Chemical Name:

    Losartan potassium

  • Synonyms:

    1H-Imidazole-5-methanol,2-butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-,potassium salt (1:1);1H-Imidazole-5-methanol,2-butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-,monopotassium salt;DuP 753;Du Pont 753;MK 954;Losartan potassium;Cozaar;Nu-Lotan;Losartan monopotassium salt;Zaart;Losacar;Losium;Aradois;Losartan potassium salt;Losar;Presartan 50;Losata;Tancin;Amosar;Losatan potassium;Potassium 5-(4′-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-[1,1′-biphenyl]-2-yl)tetrazol-1-ide;405554-24-7;1017795-20-8;1202865-13-1;1262770-26-2

  • Categories:

    Active Pharmaceutical Ingredients  >  Circulatory System Drugs

Description

White to Off-White Crystalline PowderAs a angiotensin II receptor antagonist, Losartan Potassium is the potassium salt of losartan with antihypertensive activity, which is mainly used in the therapy of high blood pressure (hypertension) and diabetic nephropathy. It functions by relaxing blood vessels so that blood can flow more easily. It is also effective to help protect the kidneys from damage caused by diabetes and lower the risks of stroke in patients suffering from hypertension


Losartan is an angiotensin II receptor blocker used in the therapy of hypertension and diabetic nephropathy. Losartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.|Losartan Potassium is the potassium salt of losartan, a non-peptide angiotensin II receptor antagonist with antihypertensive activity. Losartan selectively and competitively binds to the angiotensin II receptor (type AT1) and blocks the binding of angiotensin II to the receptor, thus promoting vasodilatation and counteracting the effects of aldosterone. Converted from angiotensin I by angiotensin-converting enzyme (ACE), angiotensin II stimulates the adrenal cortex to synthesize and secrete aldosterone, decreasing sodium excretion and increasing potassium excretion, and acts as a vasoconstrictor in vascular smooth muscle.|An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.

Losartan potassium Basic Attributes

462.01

460.118068

200-287-4

3ST302B24A

DTXSID3044209

C29165

B - Blood and blood forming organs

2933290000

Characteristics

77.7

3.89590

white to off-white crystalline powder

0.986 g/mL at 25 °C(lit.)

183.5-184.5 °C

682°C at 760 mmHg

366.3ºC

n20/D 1.387(lit.)

Freely soluble in water and in methanol, slightly soluble in acetonitrile.

Desiccate at RT

1.55E-19mmHg at 25°C

Safety Information

3

36/37/38

26-36/37/39

NI6755100

Xi

|Danger|H302 (73.08%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P261, P263, P264, P270, P272, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P310, P314, P321, P330, P333+P313, P337+P313, P363, P405, and P501|Aggregated GHS information provided by 156 companies from 24 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Toxicity

Losartan has been associated with a low rate of serum aminotransferase elevations (

Drug Information

Treatment of essential hypertension|Treatment of hypertension|Proteinuria, Treatment of heart failure, Treatment of hypertension

Losartan is an angiotensin II receptor blocker used in the therapy of hypertension and diabetic nephropathy. Losartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.

Angiotensin II Receptor Antagonists

Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)|Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol

Losartan potassium Use and Manufacturing

Uses

Coronary vasodilator used in the diagnosis of coronary heart disease (adenosine A2A agonist). 1. The treatment of essential hypertension can be used alone or in combination with other antihypertensive drugs (such as diuretics). 2. The treatment of heart failure can be used alone or in combination with cardiotonic drugs and diuretics. 3. Prevent stroke in patients with hypertension and left ventricular hypertrophy. 4. Used to slow down the progression of kidney disease in type 2 diabetic patients with nephropathy and hypertension.

Human Drugs -> EU pediatric investigation plans|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:461.0
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:8
Exact Mass:460.1180685
Monoisotopic Mass:460.1180685
Topological Polar Surface Area:77.7
Heavy Atom Count:31
Complexity:526
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

No specific description provided

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • MACLEODS PHARMACEUTICALS LTD

    India India
    Active
  • VASUDHA PHARMA CHEM LIMITED

    India India
    Active
  • FAREVA LA VALLEE

    France France
    Active

Recommended Suppliers of Losartan potassium

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.